Skip to main content
Log in

Elbasvir/grazoprevir cost effective for hepatitis C in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Mattingly TJ 2nd, et al. Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What? Annals of Pharmacotherapy : 1060028017722007, Jul 2017

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elbasvir/grazoprevir cost effective for hepatitis C in USA. PharmacoEcon Outcomes News 783, 16 (2017). https://doi.org/10.1007/s40274-017-4187-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4187-1

Navigation